Form 4: USANA Health Sciences Director Acquires Shares Through Vesting of Restricted Stock Units

Frederic J Winssinger, a director at USANA Health Sciences, acquired 674 shares of common stock through the vesting of restricted stock units.

Summary

• Frederic J Winssinger, a director of USANA Health Sciences, acquired 674 shares of common stock on February 2, 2025.
• This acquisition resulted from the vesting of restricted stock units.
• The restricted stock units vest in four tranches: 25% on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
• Following this transaction, Mr. Winssinger directly owns 5,197 shares of USANA common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed as neutral to slightly positive as it aligns director interests with shareholders.

Positives

• The vesting of restricted stock units aligns the director's interests with those of the shareholders.
• The director's increased ownership demonstrates confidence in the company's future.

Industry Context

This is a routine filing related to the vesting of equity compensation for a company director, which is a common practice in publicly traded companies.

Comparison to Industry Standards

• The vesting schedule of 25% quarterly is a common practice for restricted stock units.
• Many companies use restricted stock units as part of their compensation packages for directors and executives.
• The reporting of these transactions via SEC Form 4 is a standard regulatory requirement.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

USANA Health Sciences, Director, Stock Acquisition, Restricted Stock Units, Share Vesting, Form 4, Insider Trading